Splenic Lymphomas: Is There Still a Role for Splenectomy? Cancer Network Increasing experience with rituximab (Rituxan), however, suggests that it may be reasonable to reconsider the role of splenectomy as frontline therapy for SMZL. Ultimately, the practitioner and patient must consider which intervention is most likely to ... |
